INTRODUCTION
Bhagandara is a common disease occurring in anorectal region. The word Bhagandara is the combination of two words "Bhaga" and "Daran" which are derived from root Bhaj and Dri Dhatu respectively.
[1] The literal meaning of Bhaga is Vagina.
In Madhava Nidana, Bhaga is used for Vagina, Vasti and Guda. In Bhavaprakasha it is used for Yoni and Mehana. [3] Bhaga is a word, which means all the structures around the Guda including Yoni and Basti.
The word Daran means tear of surface associated with pain. Finally it can be concluded that Bhagandara, is a pathological condition, which causes splitting / discontinuity / tear and pain, in the anorectal canal (Guda), vagina (Bhaga) or urinary bladder (Vasthi). The importance of this disease was first realized by Acharya Sushruta (800-1000 B.C.), The Father of Indian Surgery, who described it elaborately in his treatise.
In western medicine Bhagandara is compared with Fistula in ano. The word fistula is derived from a Latin word a reed, pipe or flute. It implies a chronic granulating track connecting two epithelial-lined surfaces. The anal fistula is a single track with an external opening in the skin of perianal region and an internal opening in the modified skin or mucosa of anal canal or rectum.
[12]
The anal abscess occurs in 26-38% adults in developing countries and the incidence of Fistula is about 8 -12% per 1,00,000 populations (Dr J Gnanaraj, 2016).
Acharya Sushruta in the 17 th chapter of Chikistastana mentioned the application of Ksharasutra in Nadi Vrana [4] and preparation of Kshara mentioned in 11 th chapter Sutrasthana. [2] The Kshara Sutra therapy was practiced and used since long with great success and without recurrences. The Apamarga Ksharasutra is prepared by repeated coatings of Snuhi Ksheera, Apamarga Kshara and Haridra. [5] Still some of the problems are facing during the preparation and also in the course of Ksharasutra therapy, like collection and preservation of Snuhi Ksheera, burning pain during primary and successive changes, Local irritant skin reactions during course of therapy etc. In spite of the good rates of cutting, severe pain and burning sensation caused during the treatment with held many patients from accepting this treatment. To overcome these disadvantages there is a need of most important preparation to make the treatment widely popular and acceptable.
Overcoming the causation of pain and burning sensation was a very important necessity because of which surgeons of Ayurveda came out with newer ideas. Thus it gave to many Ksharasutras were tried out. Though each of the thread had good cutting rates and other preparation advantages they also had some disadvantages. Keeping in view the same idea Palasha Ksharasutra [2] prepared in Arka Ksheera was tried in the present study.
OBJECTIVES
To evaluate the effect of Palasha Kshara Sutra prepared in Arkaksheera and to compare the effect of Palasha KsharaSutra prepared with Arkaksheera and Apamarga Kshara Sutra in the management of Bhagandara.
MATERIALS AND METHODS
Present study was an open clinical study in which 30 patients were selected on the basis of simple random sampling (SRS) procedure and divided in 2 equal groups, strictly confined to the treatment of low anal fistula (sub-cutaneous). It was performed on the patients who attended the outpatient and inpatient department of Shalya Tantra, Sri Siddharudha Chariatable Hospital, a teaching hospital of N.K.J. Ayurvedic Medical College and P.G Centre, Bidar.
Administration of inj. Tetanus toxoid.
Pradhana Karma
Group 1: Application of Palasha Ksharasutra.
For the application of Palasha Ksharasutra the patients were asked to lie in lithotomy position and perianal region was cleaned with antiseptic lotions and draped. The patients were assured and gloved finger was gently introduced into the rectum. Then a suitable selected probe was passed through the external opening of fistula. The tip of the probe was forwarded along the path of least resistance being guided by the finger in rectum to reach into the lumen of anal canal through the internal opening and its tip was finally directed to come out of anal orifice. Palasha Ksharasutra was taken and threaded into the eye of probe, thereafter the probe was pulled out through the anal orifice to leave the thread behind in the fistulous track. The two ends of the thread were then tied together with a moderate tightness outside the anal canal.
Group 2: Application of the Apamarga Ksharasutra.
For the application of Apamarga Ksharasutra, the patient were asked to lie in lithotomic position and perianal region was cleaned with antiseptic lotions and draped. Thus, the patient was assured and gloved finger was gently introduced into the rectum. Then, a suitable selected probe was passed through the external opening of fistula. The tip of the probe was forwarded along the path of least resistance being guided by the finger in rectum to reach into the lumen of anal canal through the internal opening and its tip was finally directed to come out of anal orifice. Apamarga Ksharasutra was taken and threaded into the eye of probe. Thereafter the probe was pulled out through the anal orifice to leave the thread behind in the fistulous track. The two ends of the thread were then tied together with a moderate tightness outside the anal canal.
[6]
Paschat Karma
After Application of Palasha Ksharasutra; 
Assessment Criteria
The clinical examinations of the patient were conducted before and after treatment and accordingly the effectiveness were evaluated as per the assessment criteria fixed. The subjective and objective parameters for assessment are as follows.
Subjective Parameters

Pain
Assessed by visual analog scale of pain G 0 -0 -Absence of pain/no pain. 
2) Indurations
G 0 -Absent 
3) Length of tract (in cms)
= .
Assessment of Result
For the purpose of the assessment of result we have used some grade points considering the severity of different sign and symptoms as follows.
Sign
Grade Grade Point
+++ G 3 3 ++ G 2 2 + G 1 1 - G 0 0
Clinical assessment of result
Cure -100% free from cardinal signs and symptoms, these are pain, swelling, discharge, itching, local tenderness, length of tract etc.
Max. Improvement -75% to 99% improvement of the above mentioned cardinal signs and symptoms.
Moderate Improvement -50% to 74% improvement of the above mentioned cardinal signs and symptoms.
Mild Improvement -25% to 49% improvement of the above mentioned cardinal signs and symptoms.
No. Improvement -Less than 25% improvement of the above mentioned cardinal signs and symptom.
Study Design
According to the procedure stated above thirty patients with low anal fistula were selected for the study by random sampling technique method.
Group design
BT G 1 vs AT G 1 will be assessed AT G 1 vs AT G 2 will be compared BT G 2 vs AT G 2
The clinical assessment was done in every 7 days interval. The initial findings were taken through clinically, pathologically and statements were compared with the result of progressive 7 th day, 14 th day and so on. Grading and grouping according to the assessment criteria and measurement scale concerned to each item categorically differentiated the findings among the patients in the clinical study. And finally the assessment as a whole was presented in percent value. In order to present the study in a scientific manner, the statistical assessment of the result were assessed by the result mean ± S.D of each sign and symptom before treatment has been compared with mean ± S.D value of after treatment. Paired t -test was used for the purpose of the test of significance. The effectiveness of Palasha Ksharasutra and Apamarga Ksharasutra were assessed through pvalue.
OBSERVATION AND RESULTS
The present study was carried out on total 30 patients in two groups as prospective study by simple randomized method of selection. The patients were tested in this clinical trial for Palasha Ksharasutra and Apamarga Ksharasutra. The following observations were made during the course of the present clinical research.
Incidence according to Age and Sex
It has been observed from the study that, out of 30 patients, maximum No. of patients i.e. 09 (30.00%) were in between the age group 41 to 50 years, minimum patients reported in between the age group 61 to 70 years i.e. 03(10.00%) collectively there were 23 males and 07 female patients.
Incidence according to Religion
It was evidenced from the study that, out of 30 patients, maximum No. of patients 14 (46.67%) were Muslim, 7 (23.33%) Hindu patients reported, 6 (20%)
Christian patients were found and 3 (10%) Sikh patients were reported.
Incidence according to Marital Status
This study shows that incidence of Bhagandara was more in married patients with a percentage of 73.33% (22).
Incidence according to Occupation
This study shows distribution of patients according to occupation and its percentage. Incidence was more in labour class i.e. 15 patients 50.00%, service 05 (16.67%) patients, house wife 04 (13.33%) patients, student and business 03 (10%) patients were found.
Incidence according to Education
Incidence of education status revealed that 19 patients were uneducated i.e. (63.33%) and 11 patients were educated i.e. (36.67%).
Incidence according to socioeconomic status
Analysis of socio-economic status of 30 cases of Fistula-in-ano revealed that majority of patients i.e. 15(50%) belongs to poor class, 12 (40%) patients belongs to middle class and 03 (10%) patients from rich class were reported.
Incidence according to Dietary habits
The distribution of patients reveals that the maximum numbers of cases (72.6%) were habituated to take Non-vegetarian diet. Average U.C.T. = 0.8 cm
RESULT
In the present clinical study the result of all the cases were noted on the basis of following points. The above statistical analysis shows that in case of Pain-The mean ± S.E. before treatment was 2.06±0.18 and was same 2.06±0.18 after 7 days, was reduced to 1.86±0.13 after 14 days, 1.53±0.16 after 21 days and 0.86±0.13 after 28 days. The test of significance shows that Palasha is highly significant to reduce pain with the P-value < 0.001 in AT1, AT2, AT3 and AT4 respectively.
Swelling-The mean ± S.E. before treatment was 2.21±0.18, was same 2.21±0.18 after 7 days, was reduced to 2.21±0.18 after 14 days, 1.21±0.10 after 21 days and 0.42±0.13 after 28 days. The test of significance shows that Palasha is highly Significant to reduce swelling with the P-value < 0.001 in AT1, AT2, AT3 and AT4 respectively.
Itching-The mean ± S.E. before treatment was 2.06±0.18, was same 2.06±0.18 after 7 days, 2.06±0.18 after 14 days, was reduced to 1±0.13 after 21 days and 0.4±0.13 after 28 days. The test of significance shows that Palasha is highly significant to reduce itching with the P-value < 0.001in AT1, AT2, AT3 and AT4 respectively.
Discharge-The mean ± S.E. before treatment was 2.33±0.18, was same 2.33±0.18 after 7 days, was reduced to 1.73±0.15 after 14 days, and 1.2±0.10 after 21 days and 0.46±0.13 after 28 days. The test of significance shows that Palasha is highly significant to reduce discharge with the P-value < 0.001 in AT1, AT2, AT3 and AT4 respectively.
Local of Tenderness-The mean ± S.E. before treatment was, 2.4±0.13 and was same 2.4±0.13 after 7 days, was reduced to1.73±0.15 after 14 days and 1.2±0.10 after 21 days, 0.66±0.12 after 28 days. The test of significance shows that Palasha is highly significant to reduce local tenderness with the P-value < 0.001 in AT1, AT2, AT3 and AT4 respectively.
Length of track-The mean ± S.E. before treatment was 3.46±0.17 and was same 3.46±0.17 after 7 days, were reduced to 2.50±0.17 after 14 days, 1.57±0.14 after 21 days and 0.57±0.10 after 28 days. The test of significance shows that Palasha is highly Significant to reduce length of track with the P-value < 0.001 in AT1, AT2, AT3 and AT4 respectively. The above statistical analysis shows that in case of Pain -The mean ± S.E.1.53±0.16 before treatment was same 1.53±0.16 after 7 days, was reduced to 1.73±0.15 after 14 days, 1.26±0.15 and after 21 days. 0.73±0.11 after 28 days. The test of significance shows that Apamarga is highly Significant to reduce pain with the P-value <0.001 in AT1, AT2, AT3 and AT4 respectively.
Swelling -The mean ± S.E. before treatment was 2.13±0.16 and was same 2.13±0.16 after 7 days, was reduced to 2.06±0.18 after 14 days, 1.13±0.135 after 21 days and 0.2±0.10 after 28 days. The test of significance shows that Apamarga is highly significant to reduce swelling with the P-value <0.001 in AT1, AT2, AT3 and AT4 respectively.
Itching -The mean ± S.E. before treatment was 2.06±0.18 and was same 2.06±0.18 after 7 days, was reduced to 1.86±0.13 after 14 days, and 0.86±0.13 after 21 days and 0.2±0.10 after 28 days. The test of significance shows that Apamarga is highly significant to reduce itching with the P-value < 0.001 in AT1, AT2, AT3 and AT4 respectively.
Discharge -The mean ± S.E. before treatment was 2.13±0.13, was same 2.13±0.13 after 7 days, was reduced 1.6±0.13 after 14 days, 1±0 after 21 days and 0.2±.10 after 28 days. The test of significance shows that Apamarga is highly significant to reduce discharge with the P-value < 0.001 in AT1, AT2, AT3 and AT4 respectively.
Local of Tenderness -The mean ± S.E. before treatment was 2.4±0.13, was same 2.4±0.13 after 7 days, was reduced to1.6±0.13 after 14 days, 1.33±0.09 after 21 days and 0.33±0.12 after 28 days. The test of significance shows that Apamarga is highly significant to reduce local tenderness with the P-value <0.001 in AT1, AT2, AT3 and AT4 respectively.
Length of track -
The mean ± S.E. before treatment was 4.2±0.25 and was same 4.2±0.25 after 7 days, was reduced 3.10±0.25 after 14 days, and 1.97±0.25 after 21 days, 0.82±0.19 after 28 days. The test of significance shows that Apamarga is highly significant to reduce Length of track with the P-value <0.001 in AT1, AT2, AT3 and AT4 respectively.
Overall clinical assessment of therapy
In Group I, 12 patients (80%) completely cured. In group II, 14 patients (93.33%) got completely cured. Finally overall assessment of the therapy was analyzed clinically. 
DISCUSSION
The assessment of results is mainly based on parameters like pain, swelling, itching, discharge, induration, tenderness and unit cutting time (UCT).
Discussion on Pain:
In the trial group before treatment mean and SE assessed over the pain were 2.06 after the treatment it was reduced to 0.86 showing highly significant effect because of Vedana Shamaka, Ksharana, Teekshna and Ushnaguna and chemical constituents butin, calotropian, glycosides are having pain relieving properties of the Palashakshara and Arkaksheera definitely debribes fistula tract followed with continuous pus drainage subsequently reduces pain.
[9]
Discussion on Swelling: In the trial group before treatment mean and SE assessed over the induration was 2.21 after the treatment it was reduced to 0.42 showing highly significant effect because of Antikatu, Tikta, Kashaya Rasa, Laghu, Ruksha, Teekshnaguna, Ushnaveerya of the proposed drug reduces the tissue response.
Discussion on Itching: In the trial group before treatment mean and SE assessed over the itching was 2.06 after the treatment it was reduced to 0.4 showing highly significant effectbecause of Krimigna, Kandugna properties of Palashakshara and Arkaksheera possesses the antipruritic action.
[40]
Chemical constituents butin, tannin, protimin, calotropian are having antifungal property which reduces itching.
[11]
Discussion on Discharge: In the trial group before treatment mean and SE assessed over the discharge was 2.33 after the treatment it was reduced to 0.46 showing highly significant effect, debribment action of the Ksharana, Vranaropana properties of Palashakshara and Arkaksheera definitely reduces the different type of discharges.
[10] Discussion on Induration: In the trial group before treatment mean and SE assessed over the induration was 2.21 after the treatment it was reduced to 0.42 showing highly significant effect because of Antikatu, Tikta, Kashaya Rasa, Laghu, Ruksha, Teekshnaguna, Ushnaveerya of the proposed drug reduces the tissue response.
[9] Discussion on Tenderness: In the trial group before treatment mean and SE assessed over the local tenderness was 2.4 after the treatment it was reduced to 0.66 showing highly significant effect because Vedanashamaka properties, butin, monospermin, tannin and proteolitin chemical constituents of the proposed drug increases cutting rate of the fistulas tract subsequently reduces the surrounding tenderness.
[10]
Discussion on Unit Cutting Time: Average U.C.T. is 0.8cm/day in control group compared to 0.68cm/day in trial group. In the trial group before treatment mean and SE assessed over the length of track were 3.46 after the treatment it was reduced to 0.57 showing highly significant effect. The average UCT was 0.68cms/day. Because Palashaksharasutra prepared with Arkaksheera having the Chedana, Bhedana, Ksharana and Ropana properties of proposed drug may reduce the length of the tract. Apamarga Ksharasutra is alkaline and its pH is 9.72, whereas Palasha Ksharasutra is alkaline with pH of 7.5. So the pain and burning sensation was comparatively less in trial group with U.C.T. almost equal to control group 0.8cm/day in control group compared to 0.68cm/day in trial group. patients (80%) were cured and maximum improvement in 3 patients (20%). Group -II, 14 patients (93.33%) were cured and maximum improvement in 1 patient (6.66%).
After comparison of all above figures of signs and symptoms in trial and control groups, we can conclude that the treatment used in Bhagandara (Fistula-in-ano) Palashaksharasutra prepared with Arkaksheera is having equipotent result as compared to Apamargaksharasutra.
CONCLUSION
Based on the above clinical statistical data it may be concluded that the management of Bhagandara by Ksharasutra has been proved effective by this study. The undesired effects of Ksharasutra management could be minimized by using Palasha Ksharasutra prepared with Arkaksheera. Palasha Ksharasutra prepared in Arkaksheera has been found very effective in relieving symptoms i.e. reduces pain, swelling, itching, discharge and local tenderness in fistula in short duration. Palasha Ksharasutra prepared with Arkaksheera is best alternative to Apamarga Ksharasutra prepared in Snuhiksheera in the management of Bhagandara.
